Pharmalot Ed Silverman Pharmalittle: Four drug companies settle Ohio opioid suit; J&J recalls baby powder due to asbestos
Pharmalot Ed Silverman FTC warns lawyers about deceptive ads for generating lawsuits over drug side effects
Pharmalot Ed Silverman Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens
Pharmalot Ed Silverman Nuclear pharmacies sue a key supplier of radiology medicines for pursuing an ‘illegal monopoly’
Pharmalot Ed Silverman Pharmalittle: Trump grows frustrated over drug pricing; FDA enforcement declines under Trump
Pharmalot Ed Silverman Pharmalittle: Colorado is first U.S. state to cap insulin prices; JP Morgan cuts ties with Purdue
Pharmalot Ed Silverman Baltimore sues a J&J unit over ‘sham’ patent litigation to extend its monopoly on a cancer drug
Pharmalot Ed Silverman Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says
Pharmalot Ed Silverman A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe
Pharmalot Ed Silverman Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug
Pharmalot Ed Silverman A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute
Pharmalot Ed Silverman Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award
Pharmalot Ed Silverman Pharmalittle: Sanofi to refund Philippines for dengue vaccine; Google backs universal flu vaccine
Pharmalot Ed Silverman Allergan to pay $4 million to settle sex discrimination charges by former sales reps
Pharmalot Ed Silverman Pharmalittle: Shire CFO will be leaving; J&J hit with $417 million talc verdict